Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon

Charlotte Boullé¹, Charles Kouanfack, Gabrièle Laborde-Balen, Avelin Fobang Aghokeng, Sylvie Boyer, Maria Patrizia Carrieri, Serge Kazé, Jean-Marc Mben, Marlise Dontsop, Bruno Spire, Martine Peeters, Eitel Mpoudi-Ngolé, Eric Delaporte, Christian Laurent; Stratall ANRS 12110/ESTHER Study Group

Collaborators, Affiliations

Collaborators

Stratall ANRS 12110/ESTHER Study Group:
M Biwolé-Sida, C Kouanfack, S Koulla-Shiro, A Bourgeois, E Delaporte, C Laurent, M Peeters, G Laborde-Balen, M Dontsop, S Kazé, J-M Mben, A Aghokeng, M G Edoul, E Mpoudi-Ngolé, M Tongo, S Boyer, M P Carrieri, F Marcellin, J-P Moatti, B Spire, C Abé, S-C Abega, C-R Bonono, H Mimcheu, S Ngo Yebga, C Paul Bile, S Abada, T Abanda, J Baga, P Bilobi Fouda, P Etong Mve, G Fetse Tama, H Kemo, A Ongodo, V Tadewa, H D Voundi, A Ambani, M Atangana, J-C Biaback, M Kennedy, H Kibedou, F Kounga, M Maguip Abanda, E Mamang, A Mikone, S Tang, E Tchuangue, S Tchuenko, D Yakan, J Assandje, S Ebana, D Ebo'o, D Etoundi, G Ngama, P Mbarga Ango, J Mbezele, G Mbong, C Moung, N Ekotto, G Nguemba Balla, G Ottou, M Tigougmo, R Beyala, B Ebene, C Effemba, F Eyebe, M-M Hadjaratou, T Mbarga, M Metou, M Ndam, B Ngoa, E B Ngock, N Obam, A M Abomo, G Angoula, E Ekassi, J J Lentchou, I Mvilongo, J Ngapou, F Ntokombo, V Ondoua, R Palawo, S Sebe, E Sinou, D Wankam, I Zobo, B Akono, A L Ambani, L Bilock, R Bilo'o, J Boombhi, F X Fouda, M Guitonga, R Mad'aa, D R Metou'ou, S Mgbih, A Noah, M Tadena, G Ambassa Elime, A A Bonongnaba, E Foaleng, R M Heles, R Messina, O Nana Ndankou, S A Ngono, D Ngono Menounga, S S Sil, L Tchouamou, B Zambou, R Abomo, J Ambomo, C Beyomo, P Eloundou, C Ewole, J Fokom Domgue, M Mvoto, M Ngadena, R Nyolo, C Onana, A Oyie, P Antyimi, S Bella Mbatonga, M Bikomo, Y Molo Bodo, S Ndi Ntang, P Ndoudoumou, L Ndzomo, S O Ngolo, M Nkengue, Y Tchinda

Affiliation

¹ Institut de Recherche pour le Développement (IRD), University Montpellier 1, UMI 233 TransVIHMI, Montpellier, France. charlotte.boulle@ird.fr

PMID: 23667264
DOI: 10.1093/cid/cit323

Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon

Charlotte Boullé et al. Clin Infect Dis. 2013 Aug.

. 2013 Aug;57(4):604-7.

doi: 10.1093/cid/cit323. Epub 2013 May 10.

Authors

Collaborators

Stratall ANRS 12110/ESTHER Study Group:
M Biwolé-Sida, C Kouanfack, S Koulla-Shiro, A Bourgeois, E Delaporte, C Laurent, M Peeters, G Laborde-Balen, M Dontsop, S Kazé, J-M Mben, A Aghokeng, M G Edoul, E Mpoudi-Ngolé, M Tongo, S Boyer, M P Carrieri, F Marcellin, J-P Moatti, B Spire, C Abé, S-C Abega, C-R Bonono, H Mimcheu, S Ngo Yebga, C Paul Bile, S Abada, T Abanda, J Baga, P Bilobi Fouda, P Etong Mve, G Fetse Tama, H Kemo, A Ongodo, V Tadewa, H D Voundi, A Ambani, M Atangana, J-C Biaback, M Kennedy, H Kibedou, F Kounga, M Maguip Abanda, E Mamang, A Mikone, S Tang, E Tchuangue, S Tchuenko, D Yakan, J Assandje, S Ebana, D Ebo'o, D Etoundi, G Ngama, P Mbarga Ango, J Mbezele, G Mbong, C Moung, N Ekotto, G Nguemba Balla, G Ottou, M Tigougmo, R Beyala, B Ebene, C Effemba, F Eyebe, M-M Hadjaratou, T Mbarga, M Metou, M Ndam, B Ngoa, E B Ngock, N Obam, A M Abomo, G Angoula, E Ekassi, J J Lentchou, I Mvilongo, J Ngapou, F Ntokombo, V Ondoua, R Palawo, S Sebe, E Sinou, D Wankam, I Zobo, B Akono, A L Ambani, L Bilock, R Bilo'o, J Boombhi, F X Fouda, M Guitonga, R Mad'aa, D R Metou'ou, S Mgbih, A Noah, M Tadena, G Ambassa Elime, A A Bonongnaba, E Foaleng, R M Heles, R Messina, O Nana Ndankou, S A Ngono, D Ngono Menounga, S S Sil, L Tchouamou, B Zambou, R Abomo, J Ambomo, C Beyomo, P Eloundou, C Ewole, J Fokom Domgue, M Mvoto, M Ngadena, R Nyolo, C Onana, A Oyie, P Antyimi, S Bella Mbatonga, M Bikomo, Y Molo Bodo, S Ndi Ntang, P Ndoudoumou, L Ndzomo, S O Ngolo, M Nkengue, Y Tchinda

Affiliation

¹ Institut de Recherche pour le Développement (IRD), University Montpellier 1, UMI 233 TransVIHMI, Montpellier, France. charlotte.boulle@ird.fr

PMID: 23667264
DOI: 10.1093/cid/cit323

Erratum in

Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon.
[No authors listed] [No authors listed] Clin Infect Dis. 2025 Feb 5;80(1):241. doi: 10.1093/cid/ciaf001. Clin Infect Dis. 2025. PMID: 39777478 No abstract available.

Abstract

Our study in Cameroonian rural district hospitals showed that the immunologic and clinical failure criteria had poor performance to identify human immunodeficiency virus drug resistance in a timely manner. Switching to second-line antiretroviral therapy after 2 consecutive viral loads ≥5000 copies/mL, as recommended by the World Health Organization, appeared to be the most appropriate strategy.

Keywords: Africa; HIV; failure; resistance; switch.

PubMed Disclaimer

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon

Collaborators

Affiliation

Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon

Authors

Collaborators

Affiliation

Erratum in

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical